[
  {
    "ts": null,
    "headline": "Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
    "summary": "Danaher Corporation (NYSE: DHR) (\"Danaher\"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.",
    "url": "https://finnhub.io/api/news?id=ee69833e9350d89fafb1214ebbd00b513c8cb39f53e71051e08c6ac3b287c3fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748550600,
      "headline": "Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
      "id": 134848105,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE: DHR) (\"Danaher\"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.",
      "url": "https://finnhub.io/api/news?id=ee69833e9350d89fafb1214ebbd00b513c8cb39f53e71051e08c6ac3b287c3fd"
    }
  }
]